Does RETIFANLIMAB Cause Disease progression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Disease progression have been filed in association with RETIFANLIMAB (ZYNYZ). This represents 11.5% of all adverse event reports for RETIFANLIMAB.
11
Reports of Disease progression with RETIFANLIMAB
11.5%
of all RETIFANLIMAB reports
10
Deaths
10
Hospitalizations
How Dangerous Is Disease progression From RETIFANLIMAB?
Of the 11 reports, 10 (90.9%) resulted in death, 10 (90.9%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for RETIFANLIMAB.
What Other Side Effects Does RETIFANLIMAB Cause?
Diarrhoea (23)
Nausea (14)
Neutrophil count decreased (12)
White blood cell count decreased (12)
Neutropenic sepsis (11)
Condition aggravated (9)
Pulmonary embolism (9)
Pyrexia (9)
Asthenia (8)
Blood sodium decreased (8)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)